Search for Clinical Trial Results
Primary Sclerosing Cholangitis - 31 Studies Found
Status | Study |
Recruiting |
Study Name: Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Condition: Primary Sclerosing Cholangitis Date: 2016-06-13 Interventions:
|
Completed |
Study Name: Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis (PSC) Date: 2012-08-22 Interventions:
|
Active, not recruiting |
Study Name: Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis (PSC) Date: 2014-06-26 Interventions:
|
Completed |
Study Name: Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis (PSC) Date: 2014-02-11 Interventions: Drug: LUM001 LUM001 oral dose |
Recruiting |
Study Name: Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures Condition: Primary Sclerosing Cholangitis Date: 2015-12-09 Interventions: Device: probe based confocal laser endomicroscopy real-time, microscopic imaging of tissue at the cellul |
NOT_YET_RECRUITING |
Study Name: CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) Condition: Date: 2024-05-19 Interventions: Oral QD |
RECRUITING |
Study Name: Detoxification of the Liver In PSC (Dolphin) Condition: Primary Sclerosing Cholangitis Date: 2024-05-19 Interventions: Groups 1, 2, 3, and 4 will all contain 7 subjects each, with each subject receiving active study drug and placebo in a randomized order; half will rec |
RECRUITING |
Study Name: Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach Condition: Primary Sclerosing Cholangitis Date: 2024-05-19 |
RECRUITING |
Study Name: Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study Condition: Primary Sclerosing Cholangitis Date: 2024-05-19 Interventions: Rosuvastatin 20 mg tablet once daily by mouth |
RECRUITING |
Study Name: A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. Condition: Primary Sclerosing Cholangitis Date: 2024-05-19 Interventions: Oral Tablet |